Skip to main content

USMJ 420 Outlook Includes CBD And Adult Use Marijuana Sales Growth

Written by Customer Service on . Posted in Public Companies.

Dallas, Texas, March 21, 2022 (GLOBE NEWSWIRE) — North American Cannabis Holdings, Inc. (OTC Pink: USMJ), with the annual 420 anniversary only one month away, today highlighted the company’s CBD and adult-use marijuana sales growth outlook.

“USMJ is ready to hit its stride this 420 [April 20, 2022] following the reorganization of PURA and PJET with USMJ becoming the cannabis sector focus,” said USMJ CEO Steven Rash. “We are excited for the annual upcoming 420 anniversary and optimistic this 420 will coincide with an overall bullish market revival.”

USMJ, Puration, Inc. (OTC Pink: PURA) and Priority Aviation, Inc. (OTC Pink: PJET) are all controlled by ACI Conglomerated.  ACI, last year reorganized its operations across the three companies with USMJ becoming the central cannabis sector company.

USMJ recently relaunched the EVERx CBD Sports Nutrition Beverage at the annual Arnold Sports Festival and now has plans to move into the adult-use marijuana market.

New York recently passed a new law to provide provisional marijuana cultivation licenses to existing hemp businesses. USMJ has confirmed its eligibility to apply for the new adult-use marijuana cultivation license recently passed into law in the State of New York.

USMJ has a subsidiary that has been growing hemp for CBD for the past four years.  The subsidiary last week received an invitation from the New York Office of Cannabis Management (OCM) to apply for the provisional adult-use cannabis license.

USMJ is founded on the core belief that cannabis makes people’s lives better. Cannabis can fight disease, improve wellness and do so in an environmentally sustainable manner. North American Cannabis Holdings is dedicated to finding the best possible applications for cannabis to serve consumers. The Company operates USMJ.com and is dedicated to Ongoing Cannabis Consumer Product Development that it can incubate into Future Spin-offs.

USMJ has one spin-off and dividend issuance so far in its cannabis incubation operational history having issued shares of Puration, Inc. (OTC Pink: PURA) to USMJ shareholders in the past. USMJ continues to work closely with PURA and recently acquired a CBD sports nutrition beverage product from PURA in a royalty agreement. The EVERx CBD Sports Nutrition Beverage acquired by USMJ is bottled by Alkame Holdings, Inc. (OTC Pink: ALKM).

Visit the company’s ecommerce site now and bookmark the site to watch for more coming announcements and updates: www.USMJ.com

Contact:
USMJ
Steven Rash
info@aciconglomerated.com
+1 (800) 861-1350

Disclaimer/Safe Harbor: This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that Alkame will achieve significant sales, the failure to meet schedule or performance requirements of the Company’s contracts, the Company’s liquidity position, the Company’s ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.